Scioto Biosciences is a Clinical stage biotech company dedicated to innovative research and discovery in the field of microbiome therapeutics. Our team has developed a proprietary Activated Bacterial Therapeutics (ABT) platform for delivering best-in-class, live therapeutic bacteria to the gut. Our solution is focused on the activation of beneficial bacteria that have the potential to advance healing for various diseases associated with the GI tract, Oncology and CNS indications.
View Top Employees from Scioto Biosciences, Inc| Website | http://sciotobiosciences.com/ |
| Revenue | $10 million |
| Employees | 9 (7 on RocketReach) |
| Founded | 2017 |
| Address | 1800 N. Capitol Ave E504, Indianapolis, Indiana 46202, US |
| Phone | (317) 652-1840 |
| Technologies |
JavaScript,
HTML,
PHP
+23 more
(view full list)
|
| Industry | Biotechnology, Business Services General, Business Services, Science and Engineering, Diabetes, Health Care, Life Science, Therapeutics |
| Competitors | Altucell, Cell Therapy Foundation, ProterixBio, Inc, ViThera Pharmaceuticals |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular Scioto Biosciences, Inc employee's phone or email?
Scioto Biosciences, Inc Questions
The Scioto Biosciences, Inc annual revenue was $10 million in 2024.
Phoevos Hughes is the Vice President Clinical Operations of Scioto Biosciences, Inc.
7 people are employed at Scioto Biosciences, Inc.
Scioto Biosciences, Inc is based in Indianapolis, Indiana.
The NAICS codes for Scioto Biosciences, Inc are [541714, 541, 54171, 54, 5417].
The SIC codes for Scioto Biosciences, Inc are [873, 87].
Top Scioto Biosciences, Inc Employees
-
5+3
-
44
-
View
Phoevos Hughes
Vice President Clinical Operations at Scioto Biosciences, Inc
Raleigh, North Carolina, United States41 -
5+4
-
11
-
1
-
21
Related Companies
